| Dr. Owen Garrick is Chief Operating Officer and Director at Bridge Clinical Research Inc. He is responsible for managing the Clinical Trials and Investigator Training business units, and oversees all financial, administrative, and legal aspects of the company. Prior to Bridge Clinical Research, Inc., Dr. Garrick was the Director of Corporate Strategy and Business Development at McKesson Corporation. He pursued vertical integration opportunities with generic drug manufacturers and upstream product development. He also developed and launched the company's Drug Adherence Business focused on pharmaceutical and biotechnology manufacturers. He also served as Executive Director and Co-Head of Mergers & Acquisitions at Novartis Pharmaceuticals. In this position, he led all global M&A activity up to $5 billion. He specifically oversaw small and medium size company acquisitions, hybrid equity/license right deals, mature product divestments, and venture investments in biotechnology companies. Previously he spent four years at Goldman Sachs in New York , functioning as an investment advisor working with private healthcare companies as they sought to grow, raise capital, and perform initial public offerings. Dr. Garrick earned his MD from the Yale School of Medicine and his MBA from the Wharton School of Business. He holds an AB in Psychology from Princeton University and continues to be an active alumnus, serving on the national fundraising board. He also serves on other boards and professional committees, including the New York Blood Center and the Sutter Healthcare System. |